Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

NGM Biopharmaceuticals Inc (NGM)

  • Technical Exchange News
  • April 08, 2024, 01:06 UTC
  • 27
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: NGM Biopharmaceuticals, Inc. - Common Stock.

Comment Full text

X4 Pharmaceuticals Inc. (XFOR)

  • Technical Exchange News
  • April 06, 2024, 02:00 UTC
  • 29
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Gamida Cell Ltd (GMDA)

  • Technical Exchange News
  • April 06, 2024, 02:00 UTC
  • 28
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

X4 Pharmaceuticals Inc. (XFOR)

  • Technical Exchange News
  • April 05, 2024, 18:48 UTC
  • 28
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Gamida Cell Ltd (GMDA)

  • Technical Exchange News
  • April 05, 2024, 18:47 UTC
  • 29
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Cyclacel Pharmaceuticals Inc. (CYCCP)

  • Technical Exchange News
  • April 05, 2024, 01:49 UTC
  • 29
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Cyclacel Pharmaceuticals Inc. (CYCC)

  • Technical Exchange News
  • April 05, 2024, 01:49 UTC
  • 28
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Cyclacel Pharmaceuticals Inc. (CYCCP)

  • Technical Exchange News
  • April 04, 2024, 18:47 UTC
  • 26
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Cyclacel Pharmaceuticals Inc. (CYCC)

  • Technical Exchange News
  • April 04, 2024, 18:47 UTC
  • 27
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Kinnate Biopharma (KNTE)

  • Technical Exchange News
  • April 04, 2024, 00:06 UTC
  • 26
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Kinnate Biopharma Inc. - Common Stock.

Comment Full text
  • Previous
  • 627
  • 628
  • 629
  • 630
  • 631
  • Next

Search

News categories

  • Technical Exchange News(10951)
  • Event(2415)
  • SEC News(192768)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125513)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin